Here's your TMB Tech Minute for Wednesday, January 8th.

I'm James Rundle for the Wall Street Journal.

We're exclusively reporting that advanced microdevices is investing $20 million

in drug discovery company, Absai.

The investment allows Absai to access the computing power it needs for its use of artificial

intelligence at a lower cost. It will also give

AMD a foothold in the Life Sciences market, where it aims to compete with rival

Nvidia over the growing market for AI chips. In 2023, Nvidia invested $50 million in

drug discovery company recursion pharmaceuticals, which then used its technology to underpin its AI

modeling. The deal includes

AMD taking a stake in Abside, but the chipmaker didn't disclose the amount. OpenAI CEO Sam Altman

is being sued by his sister, Anne Altman, over allegations that he sexually abused her for several

years when they were children. Altman denies the accusations.

The lawsuit alleges that the abuse occurred at their family home in Missouri from approximately 1997 through 2006. The lawsuit requests a jury trial and damages in excess of $75,000.

Sam Altman denied the accusations in a post on X yesterday and said his sister has suffered

for mental health challenges.

Wall Street Journal-Oner News Corp has a content licensing partnership with OpenAI.

And Meta says it will run a test allowing some users in the US, France and Germany to browse

listings from rival eBay on its Facebook Marketplace platform.

That comes after the European Union

ruled that the link between its classified ads platform, marketplace, and Facebook, violated

competition laws. Meta is still appealing that decision, which also levied an $825 million

...